| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Haiyan Xu | |
| Ping Jiao | |||
| P2860 | cites work | Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene | Q22299417 |
| Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance | Q24617743 | ||
| Obesity is associated with macrophage accumulation in adipose tissue | Q27860976 | ||
| Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance | Q28131660 | ||
| A human homologue of the Drosophila Toll protein signals activation of adaptive immunity | Q28131769 | ||
| Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta | Q28188643 | ||
| Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance | Q29012156 | ||
| Obesity induces a phenotypic switch in adipose tissue macrophage polarization | Q29547686 | ||
| MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity | Q29614283 | ||
| IKK-beta links inflammation to obesity-induced insulin resistance | Q29614285 | ||
| Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance | Q29614354 | ||
| Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function | Q29616104 | ||
| Obesity as a medical problem | Q29616305 | ||
| TLR4 links innate immunity and fatty acid-induced insulin resistance | Q29617577 | ||
| Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB | Q29619314 | ||
| C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus | Q29619398 | ||
| A central role for JNK in obesity and insulin resistance | Q29619778 | ||
| CCR2 modulates inflammatory and metabolic effects of high-fat feeding | Q29622869 | ||
| Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans | Q29622900 | ||
| Suppression of nuclear factor-kappaB and stimulation of inhibitor kappaB by troglitazone: evidence for an anti-inflammatory effect and a potential antiatherosclerotic effect in the obese | Q32132515 | ||
| Neutrophils transiently infiltrate intra-abdominal fat early in the course of high-fat feeding | Q33337750 | ||
| Visceral adipose tissue inflammation accelerates atherosclerosis in apolipoprotein E-deficient mice. | Q33554780 | ||
| Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance | Q33997240 | ||
| Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance | Q34137882 | ||
| Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha | Q34190131 | ||
| Evidence for a potent antiinflammatory effect of rosiglitazone | Q34325011 | ||
| Monocyte chemoattractant protein 1 in obesity and insulin resistance | Q35163496 | ||
| Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones | Q35794061 | ||
| The anti-atherogenic effects of thiazolidinediones | Q37065763 | ||
| Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice | Q37242527 | ||
| Obesity and diabetes in TNF-alpha receptor- deficient mice | Q37383968 | ||
| Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss | Q38323163 | ||
| Functional analysis of tumor necrosis factor (TNF) receptors in TNF-alpha-mediated insulin resistance in genetic obesity | Q38330921 | ||
| Low-dose rosiglitazone exerts an antiinflammatory effect with an increase in adiponectin independently of free fatty acid fall and insulin sensitization in obese type 2 diabetics | Q40312091 | ||
| High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes | Q40663999 | ||
| Preadipocyte conversion to macrophage. Evidence of plasticity. | Q40678700 | ||
| Signaling pathways utilized by tumor necrosis factor receptor 1 in adipocytes to suppress differentiation | Q40776227 | ||
| Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. | Q40816506 | ||
| A role for preadipocytes as macrophage-like cells | Q40974181 | ||
| Tumor necrosis factor increases the rate of lipolysis in primary cultures of adipocytes without altering levels of hormone-sensitive lipase | Q41462901 | ||
| Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects | Q42797512 | ||
| Altered tumor necrosis factor-alpha (TNF-alpha) processing in adipocytes and increased expression of transmembrane TNF-alpha in obesity | Q42814772 | ||
| Exclusive action of transmembrane TNF alpha in adipose tissue leads to reduced adipose mass and local but not systemic insulin resistance | Q43920014 | ||
| Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study | Q43935468 | ||
| Serum concentration of alpha-2-macroglobulin, haptoglobin and alpha-1-antitrypsin in diabetes mellitus | Q44224801 | ||
| Circulating mononuclear cells in the obese are in a proinflammatory state | Q45057039 | ||
| Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone | Q46620643 | ||
| Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects | Q47402001 | ||
| Targeted disruption of the tumor necrosis factor-alpha gene: metabolic consequences in obese and nonobese mice | Q48630964 | ||
| NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. | Q50920620 | ||
| Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. | Q51497448 | ||
| Absence of CC chemokine ligand 2 does not limit obesity-associated infiltration of macrophages into adipose tissue. | Q53556065 | ||
| Reduction of blood fibrinolytic activity in diabetes mellitus by insulin. | Q53926197 | ||
| FIBRINOLYSIS IN OBESITY | Q53973972 | ||
| Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. | Q54223604 | ||
| Aspirin and diabetes mellitus. | Q55420667 | ||
| Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance | Q56742768 | ||
| Chemokines control fat accumulation and leptin secretion by cultured human adipocytes | Q57076426 | ||
| PPARγ Activation Primes Human Monocytes into Alternative M2 Macrophages with Anti-inflammatory Properties | Q57244208 | ||
| Reappraisal of the hypoglycemic action of acetylsalicylate. | Q64982618 | ||
| Serum sialic acid and acute phase proteins in type 1 and type 2 diabetes mellitus | Q71609492 | ||
| KB-R7785, a novel matrix metalloproteinase inhibitor, exerts its antidiabetic effect by inhibiting tumor necrosis factor-alpha production | Q73635302 | ||
| Transmembrane tumor necrosis factor (TNF)-alpha inhibits adipocyte differentiation by selectively activating TNF receptor 1 | Q78208083 | ||
| Obesity and the environment: where do we go from here? | Q78947050 | ||
| Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity | Q79996607 | ||
| Adipocyte death, adipose tissue remodeling, and obesity complications | Q81234708 | ||
| On the Treatment of Glycosuria and Diabetes Mellitus with Sodium Salicylate | Q84870452 | ||
| P921 | main subject | obesity | Q12174 |
| inflammation | Q101991 | ||
| insulin resistance | Q1053470 | ||
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 25-31 | |
| P577 | publication date | 2008-10-23 | |
| P1433 | published in | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | Q5270108 |
| P1476 | title | Adipose inflammation: cause or consequence of obesity-related insulin resistance | |
| P478 | volume | 1 |
| Q49400243 | Adipocytokines in obese Ghanaian subjects with or without type 2 diabetes |
| Q35810634 | Deficiency of ACE2 in Bone-Marrow-Derived Cells Increases Expression of TNF-α in Adipose Stromal Cells and Augments Glucose Intolerance in Obese C57BL/6 Mice |
| Q86309075 | Inflammatory Signaling Involved in High-Fat Diet Induced Prostate Diseases |
| Q41101306 | Overfat Adults and Children in Developed Countries: The Public Health Importance of Identifying Excess Body Fat. |
| Q33972551 | Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey |
| Q37704979 | microRNAs as a new mechanism regulating adipose tissue inflammation in obesity and as a novel therapeutic strategy in the metabolic syndrome |
Search more.